UNIPEX acquired by BARENTZ
Context
Barentz acquired 100% of Unipex from its management team and BNP Paribas Developpement (who held ~27%). This transaction marks the successful conclusion of the OBO structure set up in 2019. The deal was negotiated bilaterally (pre-empting a broader auction). Unipex brings EUR90 million in additional revenue and strengthens Barentz's position in France and North Africa, where the Dutch group was historically underrepresented.
It is worth noting that the fund Bnp Paribas Developpement took control of Unipex through an LBO in 2019.
UNIPEX, which reported an EBITDA margin of in 2021, is valued in this transaction at an EV/EBITDA multiple of , a level to compare with the average currently observed in the Business Services sector (11.4x).
-> Deep-dive in Business Services market trends
Target
Unipex is a distributor of specialty ingredients acting as an intermediary between chemical producers and manufacturers. The company serves the pharmaceutical, cosmetic, chemical, and food industries. It distributes approximately 1,700 ingredients to 1,600 clients across France, Benelux, and North Africa. Originally a division of the Unipex Group, it became independent in 2015. In 2018, the company generated EUR92 million in revenue.
Ent. Value
Equity Value
Multiples
EV / Revenue
EV / EBITDA
EV / EBIT
Historical Financials (EUR)
Other operations with UNIPEX
| Date | Acquirer | Target | Country | Sector |
|---|---|---|---|---|
| 10/2019 | BNP PARIBAS DEVELOPPEMENT | UNIPEX | FRANCE | B2B Specialized Distribution |
REFERENCES
Revenue range: 50M - 100M EUR
Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of UNIPEX by BARENTZ are reserved for mynth community members. Register for free to unlock full data.
Authors: This transaction was contributed by a verified mynth contributor and cross-checked against available transaction documents and official company communications.
Acquirer: barentz